IP Library Granted Patent US 9,845,476
Granted Patent B2
US 9,845,476 · App. 15/213,721 · Granted Dec 19, 2017

Targeted gene deletions for polysaccharide slime formers

Inventors: Nancy E. Harding (San Diego, CA); Yamini N. Patel (San Diego, CA); Russell J. Coleman (San Diego, CA)
Assignee: CP Kelco U.S., Inc.
C12N15/74C07K14/195C12N15/52C12P19/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,845,476
App. No.
15/213,721
Granted
Dec 19, 2017
Kind
B2
Abstract

The present invention provides improved polysaccharides (e.g., gellan and diutan) produced by mutant gene R, M or N Sphingomonas strains containing at least one genetic modification that favors slime-forming polysaccharide production. Methods of making the mutant Sphingomonas strains and the culture broth containing such mutant Sphingomonas strains are also provided.

Claims (7)

1. A Sphingomonas mutant strain comprising a mutation in gelM gene, wherein said Sphingomonas mutant strain has been genetically engineered to eliminate expression of gene gelM, wherein said mutant strain produces gellan, wherein said gellan is a slime form polysaccharide, and wherein said gellan has improved rheology, as compared to gellan naturally produced by the wild-type Sphingomonas strain ATCC 31461.

2. The Sphingomonas mutant strain of claim 1 , wherein said mutation in gene gelM comprises an insertion, deletion, or substitution in gene gelM so as to inactivate gene gelM.

3. The Sphingomonas mutant strain of claim 2 , wherein said mutation comprises a deletion in gene gelM.

4. The Sphingomonas mutant strain of claim 1 , further comprising a second gene mutation, comprising an insertion, deletion, or substitution.

5. The Sphingomonas mutant strain of claim 4 , wherein second gene mutation is in gene gelN.

6. The Sphingomonas mutant strain of claim 4 , wherein said second gene mutation is in gene gelI.

7. The Sphingomonas mutant strain of claim 4 , wherein said gellan has improved gel strength, as compared to gellan naturally produced by the wild-type Sphingomonas strain ATCC 31461.

Continuity (5)
Division 14256117 · Apr 18, 2014
Division 12983935 · Jan 4, 2011
Division 11347341 · Feb 3, 2006
Provisional Application 60649559 · Feb 4, 2005
Related Publication 20170002367A1 · Jan 5, 2017